FTI Consulting Appoints Shaun Rangappa, MD, MSHA, as Chief Clinical Executive and Senior Managing Director in Healthcare Business Transformation Practice
FTI Consulting (NYSE:FCN) has appointed Dr. Shaun Rangappa as Senior Managing Director in its Healthcare Business Transformation practice and Chief Clinical Executive. Dr. Rangappa brings over 30 years of healthcare experience and will be based in Washington, D.C.
A University of Virginia School of Medicine graduate, Dr. Rangappa will advise healthcare clients on strategy, operations, transformation, and workforce challenges. His expertise spans clinical practice, performance improvement, technology enablement, and change management. Prior to joining FTI, he spent 20 years at Deloitte Consulting's Life Sciences and Healthcare practice, leading large-scale transformations across commercial and federal clients.
FTI Consulting (NYSE:FCN) ha nominato Dr. Shaun Rangappa Senior Managing Director nella sua practice Healthcare Business Transformation e Chief Clinical Executive. Il Dr. Rangappa porta con sé oltre 30 anni di esperienza nel settore sanitario e sarà con sede a Washington, D.C.
Laureato alla University of Virginia School of Medicine, il Dr. Rangappa consulenterà i clienti del settore sanitario su strategia, operazioni, trasformazione e gestione delle risorse umane. Le sue competenze comprendono la pratica clinica, il miglioramento delle performance, l’abilitazione tecnologica e la gestione del cambiamento. Prima di entrare in FTI, ha trascorso 20 anni nella practice Life Sciences and Healthcare di Deloitte Consulting, guidando trasformazioni su larga scala per clienti commerciali e federali.
FTI Consulting (NYSE:FCN) ha nombrado a Dr. Shaun Rangappa Senior Managing Director en su práctica de Healthcare Business Transformation y Chief Clinical Executive. El Dr. Rangappa aporta más de 30 años de experiencia en el sector sanitario y estará radicado en Washington, D.C.
Graduado por la University of Virginia School of Medicine, el Dr. Rangappa asesorará a clientes sanitarios en estrategia, operaciones, transformación y retos de plantilla. Su experiencia abarca la práctica clínica, la mejora del rendimiento, la habilitación tecnológica y la gestión del cambio. Antes de incorporarse a FTI, pasó 20 años en la práctica Life Sciences and Healthcare de Deloitte Consulting, liderando transformaciones de gran envergadura para clientes comerciales y federales.
FTI Consulting (NYSE:FCN)은(는) Dr. Shaun Rangappa를 Healthcare Business Transformation 팀의 Senior Managing Director 겸 Chief Clinical Executive로 임명했습니다. Rangappa 박사는 30년 이상의 의료 분야 경험을 보유하고 있으며 워싱턴 D.C.에 근무하게 됩니다.
버지니아 대학교 의과대학(University of Virginia School of Medicine) 출신인 Rangappa 박사는 전략, 운영, 혁신 및 인력 문제 등 의료 고객을 대상으로 자문을 제공할 예정입니다. 그의 전문 분야는 임상 실무, 성과 개선, 기술 도입, 변화 관리에 걸쳐 있습니다. FTI 합류 이전에는 Deloitte Consulting의 Life Sciences and Healthcare 부문에서 20년을 근무하며 상업 및 연방 고객을 대상으로 대규모 혁신을 이끌었습니다.
FTI Consulting (NYSE:FCN) a nommé Dr. Shaun Rangappa Senior Managing Director au sein de sa practice Healthcare Business Transformation et Chief Clinical Executive. Le Dr Rangappa apporte plus de 30 ans d'expérience dans le domaine de la santé et sera basé à Washington, D.C.
Diplômé de la University of Virginia School of Medicine, le Dr Rangappa conseillera les clients du secteur de la santé sur la stratégie, les opérations, la transformation et les enjeux de main-d'œuvre. Son expertise couvre la pratique clinique, l'amélioration de la performance, l'implémentation technologique et la gestion du changement. Avant de rejoindre FTI, il a passé 20 ans au sein de la practice Life Sciences and Healthcare de Deloitte Consulting, où il a piloté des transformations à grande échelle pour des clients commerciaux et fédéraux.
FTI Consulting (NYSE:FCN) hat Dr. Shaun Rangappa zum Senior Managing Director in der Healthcare Business Transformation-Practice und zum Chief Clinical Executive ernannt. Dr. Rangappa verfügt über mehr als 30 Jahre Erfahrung im Gesundheitswesen und wird in Washington, D.C. ansässig sein.
Als Absolvent der University of Virginia School of Medicine wird Dr. Rangappa Gesundheitskunden in Fragen der Strategie, der Betriebsführung, der Transformation und der Personalherausforderungen beraten. Sein Fachwissen umfasst klinische Praxis, Leistungsverbesserung, Technologieförderung und Change Management. Vor seinem Wechsel zu FTI war er 20 Jahre in der Life Sciences and Healthcare-Practice von Deloitte Consulting tätig und leitete groß angelegte Transformationsprojekte für kommerzielle und staatliche Kunden.
- Strategic hire brings 30+ years of healthcare industry expertise
- Expansion of healthcare consulting capabilities across multiple service areas
- Addition of experienced leadership in large-scale healthcare transformations
- None.
WASHINGTON, Sept. 08, 2025 (GLOBE NEWSWIRE) -- FTI Consulting, Inc. (NYSE: FCN) today announced the appointment of Shaun Rangappa, MD, MSHA, as a Senior Managing Director in the Healthcare Business Transformation practice within the firm’s Corporate Finance & Restructuring segment.
A graduate of the University of Virginia School of Medicine, Dr. Rangappa brings over 30 years of experience in healthcare, spanning clinical practice, clinical process evaluation and performance improvement, technology enablement, governance, leadership and change management.
Dr. Rangappa, who is based in Washington, D.C., will also serve as Chief Clinical Executive within the Healthcare Business Transformation practice, supporting the firm’s healthcare industry offerings across Physician Ambulatory Services, Digital Health, Revenue Cycle Management, Clinical Operations, Workforce Management and more.
In his role, Dr. Rangappa will advise healthcare clients on strategy, operations, transformation and workforce challenges, helping them navigate ongoing disruption in the healthcare landscape.
“Our healthcare clients are facing mounting pressures, from financial and operational strain to leadership turnover and physician burnout,” said Brian Flynn, Leader of the Healthcare Business Transformation practice at FTI Consulting. “Shaun’s perspective as a trusted clinician advisor offers a rare and valuable lens to our growing healthcare work, and we are thrilled to add his talents to our expanding team as we support clients through their most complex transformations.”
Prior to joining FTI Consulting, Dr. Rangappa spent 20 years in Deloitte Consulting’s Life Sciences and Healthcare practice, where he helped lead numerous large-scale transformations across commercial and federal clients.
Commenting on his appointment, Dr. Rangappa said, “FTI Consulting has built a world-class team in healthcare, with a reputation for delivering agile and evidence-based solutions. The firm’s expertise in guiding clients through disruption and transformation is exceptional. I am excited to join a team that is truly dedicated to making a significant impact.”
About FTI Consulting
FTI Consulting, Inc. is a leading global expert firm for organizations facing crisis and transformation, with more than 7,900 employees located in 32 countries and territories as of June 30, 2025. In certain jurisdictions, FTI Consulting’s services are provided through distinct legal entities that are separately capitalized and independently managed. The Company generated
FTI Consulting, Inc.
555 12th Street NW
Washington, DC 20004
+1.202.312.9100
Investor Contact:
Mollie Hawkes
+1.617.747.1791
mollie.hawkes@fticonsulting.com
Media Contact:
Sam Ford
+1.617.480.7402
Samantha.ford@fticonsulting.com
FAQ
Who is Dr. Shaun Rangappa and what is his new role at FTI Consulting (NYSE:FCN)?
What experience does Dr. Rangappa bring to FTI Consulting (NYSE:FCN)?
What services will Dr. Rangappa oversee at FTI Consulting?
Why did FTI Consulting (NYSE:FCN) appoint Dr. Rangappa?
